Review: taking Aleve and Carbamazepine together


Summary

Drug interactions are reported among people who take Aleve and Carbamazepine together. This review analyzes the effectiveness and drug interactions between Aleve and Carbamazepine. It is created by eHealthMe based on reports of 92 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Aleve and Carbamazepine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Aleve

Aleve has active ingredients of naproxen sodium. It is often used in joint pain. (latest outcomes from Aleve 18,998 users)

Carbamazepine

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. (latest outcomes from Carbamazepine 15,574 users)

On Jul, 22, 2016

92 people who take Aleve, Carbamazepine are studied.


Number of reports submitted per year:

Aleve and Carbamazepine drug interactions.

Drug effectiveness over time:

Aleve:
  • < 1 month: 40.0% - (2 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Carbamazepine:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Aleve:
  • female: 40.0% - (2 of 5 people)
  • male: 66.0% - (2 of 3 people)
Carbamazepine:
  • female: 28.0% - (2 of 7 people)
  • male: 100.0% - (3 of 3 people)

Drug effectiveness by age:

Aleve:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 66.0% - (2 of 3 people)
Carbamazepine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 75.0% - (3 of 4 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • asthma
  • ehlers-danlos syndrome
  • epilepsy
  • gastroparesis
  • high blood pressure
  • loss of consciousness
  • potassium - low
  • abdominal discomfort
  • asthenia
  • confusional state
1 - 6 months:
  • anticonvulsant drug level decreased
  • chest discomfort
  • convulsion
  • dizziness
  • fatigue
  • malaise
  • ventricular arrhythmia
1 - 2 years:
  • anticonvulsant drug level decreased
  • convulsion
5 - 10 years:
  • fatigue
  • kidney failure
  • loss of appetite
  • nausea
  • urine - abnormal color
10+ years:
  • fatigue
  • kidney failure
  • loss of appetite
  • nausea
  • urine - abnormal color
not specified:
  • headache
  • insomnia
  • depression
  • tremor
  • vomiting
  • drug withdrawal syndrome
  • hyperhidrosis
  • irritability
  • nausea
  • diarrhoea

Most common drug interactions by gender *:

female:
  • headache
  • arthralgia
  • fatigue
  • dizziness
  • hyperhidrosis
  • insomnia
  • muscular weakness
  • obesity
  • pyrexia
  • tremor
male:
  • nausea
  • headache
  • depression
  • insomnia
  • vomiting
  • diarrhoea
  • drug dependence
  • drug withdrawal syndrome
  • hyperhidrosis
  • irritability

Most common drug interactions by age *:

10-19:
  • discomfort
  • lymphocyte percentage increased
  • oxygen saturation decreased
  • pyrexia
  • restlessness
  • sinus tachycardia
  • urinary tract infection enterococcal
  • urinary tract infection staphylococcal
  • white blood cell count increased
20-29:
  • accidental overdose
  • splenomegaly
  • anxiety
  • pyrexia
  • abdominal pain
  • abdominal pain upper
  • anaphylactic reaction
  • chest pain
  • cholecystitis chronic
  • cholelithiasis
30-39:
  • tremor
  • drug withdrawal syndrome
  • headache
  • irritability
  • back pain
  • depression
  • hyperhidrosis
  • insomnia
  • nausea
  • pain in extremity
40-49:
  • headache
  • nausea
  • depression
  • diarrhoea
  • drug dependence
  • drug withdrawal syndrome
  • fatigue
  • hyperhidrosis
  • insomnia
  • irritability
50-59:
  • muscular weakness
  • abdominal discomfort
  • confusional state
  • decreased appetite
  • glossodynia
  • night sweats
  • pyrexia
  • rash
  • urinary retention
  • visual impairment
60+:
  • asthenia
  • arthralgia
  • confusional state
  • dizziness
  • fatigue
  • insomnia
  • loss of consciousness
  • neuropathy peripheral
  • ammonia increased
  • blister

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Aleve and Carbamazepine?

Can you answer these questions?

More questions for: Aleve, Carbamazepine

You may be interested in these reviews

More reviews for: Aleve, Carbamazepine

On eHealthMe, Aleve (naproxen sodium) is often used to treat joint pain. Carbamazepine (carbamazepine) is often used to treat epilepsy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.